Saw Chia L, Rakshasbhuvankar Abhijeet, Rao Shripada, Bulsara M, Patole Sanjay
1 Department of Neonatology, Princess Margaret and King Edward Hospitals, Perth, Australia.
2 Centre for Neonatal Research and Education, University of Western Australia, Australia.
J Child Neurol. 2019 Jun;34(7):402-409. doi: 10.1177/0883073819828625. Epub 2019 Mar 22.
Therapeutic hypothermia is the recommended treatment for neonates with moderate or severe hypoxic ischemic encephalopathy (HIE). There is an increasing trend to use therapeutic hypothermia even in infants with mild hypoxic ischemic encephalopathy, even though there is little evidence to support/refute this.
To estimate the incidences of mild hypoxic ischemic encephalopathy among infants who received therapeutic hypothermia, and its short- and long-term outcomes.
PubMed, Embase, CINAHL, and Cochrane library were searched to identify observational studies reporting on therapeutic hypothermia in term and near-term infants with mild hypoxic ischemic encephalopathy. The JBI (Joanna Briggs Institute) tools were used to assess the risk of bias in the included studies. Random effects meta-analysis was conducted to find out the percentage of cooled infants who had only mild hypoxic ischemic encephalopathy.
A total of 3590 citations were screened, of which 13 were included. Of the 2783 infants who received therapeutic hypothermia, 573 had mild hypoxic ischemic encephalopathy. Meta-analysis found that 22% of the infants who underwent therapeutic hypothermia had only mild hypoxic ischemic encephalopathy (95% confidence interval: 16%-27%; I statistic = 90.5%). Five studies provided information on adverse effects of therapeutic hypothermia in mild hypoxic ischemic encephalopathy. The reported adverse effects were extreme hypothermia, bradycardia, hypoglycemia, sepsis, skin necrosis, pulmonary hypertension, and systemic hypotension. Limitation: The limitations included relatively small sample size and the lack of data for short- and long-term neurodevelopmental outcome.
A significant proportion of infants who received therapeutic hypothermia had mild hypoxic ischemic encephalopathy. Randomized trials are urgently needed to evaluate the efficacy and safety of therapeutic hypothermia in infants with mild hypoxic ischemic encephalopathy.
治疗性低温是中度或重度缺氧缺血性脑病(HIE)新生儿的推荐治疗方法。即使在轻度缺氧缺血性脑病婴儿中,使用治疗性低温的趋势也在增加,尽管几乎没有证据支持/反驳这一点。
评估接受治疗性低温的婴儿中轻度缺氧缺血性脑病的发生率及其短期和长期预后。
检索了PubMed、Embase、CINAHL和Cochrane图书馆,以确定关于足月和近足月轻度缺氧缺血性脑病婴儿治疗性低温的观察性研究。使用JBI(乔安娜·布里格斯研究所)工具评估纳入研究的偏倚风险。进行随机效应荟萃分析,以找出仅患有轻度缺氧缺血性脑病的低温治疗婴儿的百分比。
共筛选了3590条引文,其中13条被纳入。在2783例接受治疗性低温的婴儿中,573例患有轻度缺氧缺血性脑病。荟萃分析发现,接受治疗性低温的婴儿中有22%仅患有轻度缺氧缺血性脑病(95%置信区间:16%-27%;I统计量=90.5%)。五项研究提供了关于治疗性低温对轻度缺氧缺血性脑病不良影响的信息。报告的不良反应包括体温过低、心动过缓、低血糖、败血症、皮肤坏死、肺动脉高压和全身性低血压。局限性:局限性包括样本量相对较小以及缺乏短期和长期神经发育结局的数据。
接受治疗性低温的婴儿中有很大一部分患有轻度缺氧缺血性脑病。迫切需要进行随机试验来评估治疗性低温对轻度缺氧缺血性脑病婴儿的疗效和安全性。